C5AR1 and neoplasm: Furthermore, Yuan et al. used a C5aR1 inhibitor in mice with NSCLC under radiotherapy and showed an improved sensitivity and tumour response to radiotherapy, associated with increased expression of C5aR1 expression in CD8+ cells [167].